Insulin Glargine Injection

Designed to support long-term glucose stabilisation to manage diabetes mellitus symptoms and alleviate blood sugar spikes.

Dosage

Pack size

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Insulin Glargine Injection vary by destination and are determined by the fulfilment partner.

Insulin Glargine Injection details

Condition: Diabetes Mellitus
Alternative names: lantus
Therapeutic class: Long-Acting Insulin Analog
Pharmacological class: Insulin
Contraindications: hypoglycaemia; hypersensitivity to insulin glargine
Minor side effects: injection site redness; weight gain
Moderate side effects: hypoglycaemia; lipodystrophy; mild hypokalaemia
Dosage forms: Injectable Solution
Administration route: Subcutaneous use
Supply category: Prescription-only medicine (POM)
Onset Time: 1–2 hours
Duration: 24 hours
Storage instructions: Store between 2°C and 8°C. Do not freeze.
Drug interactions: Beta Blockers; Corticosteroids; Alcohol
Age restrictions: Approved for children over two years, adolescents, and adults.

Serious side effects

severe anaphylaxis, requires immediate medical attention; severe hypoglycaemia, requires immediate medical attention

Patient summary

designed to support long-term glucose stabilisation to manage diabetes mellitus symptoms and alleviate blood sugar spikes.

Mechanism of action

Binds to cell insulin receptors to stimulate peripheral glucose uptake and block glucose output from hepatic pathways.

Pregnancy and breastfeeding

TGA Category C: Deemed safe and crucial during pregnancy. Breastfeeding: Compatible.

Insulin Glargine Injection is a generic medicine sold under the name of its active ingredient, Insulin Glargine, rather than under a brand.

The fulfilment partner confirms the offered manufacturer and product before supply.
Check the active ingredient, strength, form and pack shown at checkout before confirming an order.